|
|
Please type responses here: |
|
First name:
|
|
|
Last name:
|
|
|
Email Address:
|
|
|
Retype Email Address:
|
|
|
Phone number:
|
|
|
Institution:
|
|
|
Title:
|
|
|
Address:
|
|
|
City:
|
|
|
State:
|
|
|
Country:
|
|
|
Zip/Postal Code:
|
|
|
Overall, how would you rate your satisfaction with this session?
|
Extremely satisfied
Very satisfied
Somewhat satisfied
Dissatisfied
|
|
Your feedback helps your webinar producer and sponsor improve the overall quality of their products and services.
|
|
We are considering expanding RAPID ANTIGEN testing into the following areas: (Please select all that apply)
|
Laboratory
Emergency Room
Pre-surgical Areas
Clinics/Physician Office
Urgent Care
Skilled Nursing/Long Term Care
Pharmacy
Other
None are performed outside the laboratory
Not applicable
Don’t know
|
|
We are considering expanding RAPID MOLECULAR testing (NAAT) into the following areas: (Please select all that apply)
|
Laboratory
Emergency Room
Pre-surgical Areas
Clinics/Physician Office
Urgent Care
Skilled Nursing/Long Term Care
Pharmacy
Other
None are performed outside the laboratory
Not applicable
Don’t know
|
|
How will the information provided in this program impact your practice related to rapid testing?
|
Very likely to INCREASE
Somewhat likely to INCREASE
Unsure
Somewhat likely to DECREASE
Very likely to DECREASE
|
|
Did you view this program with other colleagues?
|
Yes
No
|
|
Would you like an Abbott representative to follow-up with you?
|
Yes
No
|
|
Would you like to receive EITHER ASCLS PACE credit, program number 618-2019-22 (California Agency #0001), OR Florida CE credit, OR a certificate of attendance for the session, "2022: Rapid Testing for Infectious Diseases – A Year in Review"? (If no, you do not need to complete the following questions.)
|
Yes
No
|
|
Which continuing education credit would you like to receive for this session?
|
PACE Credit
Florida CE Credit
Certificate of Attendance
No, I would not like to receive CE credit or a certificate of attendance for today’s session
|
|
If you are planning to submit this session for Florida CE Credit, please provide your Florida license number.
|
|
|
If the following is true, please answer "Yes": I have attended the full instructional time for this program. I understand that completion of the program is necessary to receive the contact hours awarded for the program.
|
Yes
No
|
|
SPEAKER RATING
|
|
To what extent was the speaker knowledgeable, organized and effective during the presentation? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
To what extent did the speaker clarify and focus on the stated objectives? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
To what extent were the speaker's teaching methods & aids appropriate & effective? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
OBJECTIVES RATING:
To what extent was each objective achieved?
|
|
Review a year of key learnings and the evolution of testing strategies related to infectious diseases. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
Discuss the impact of the 2022-2023 respiratory season and the HIV epidemic on the community and healthcare system. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
Summarize presented data related to rapid respiratory and HIV testing and their association with antibiotic stewardship, infection control and patient outcomes. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
Examine the rapid diagnostic guidelines and featured questions from our year of 2022 webinars. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
PROGRAM CONTENT RATING
|
|
To what extent did the program content relate to the program's objectives? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
Rate the contribution of this session to your overall knowledge of this subject. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
Rate your overall degree of satisfaction with this session. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
Comments:
|
|
|
Thank you for attending this session and completing this evaluation. If you have questions, contact Whitehat Communications: 434 202 8365
|
|
|
